EGFR tyrosine kinase inhibitor ZZC4 overcomes acquired resistance to gefitinib

已取消 10 由 sifs 发布于 2026/5/28 14:07:16

DOI:10.1016/j.taap.2025.117280
作者：Mawusse K.I. Attiogbe ,?Ting-ting Huang ,?Hong-yi Zhao ,?Hong-ying Wang ,?Lei Cao ,?Ping-ping Yan ,?San-qi Zhang ,?Yong-xiao Cao
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Despite the tremendous progress of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) development, acquired resistance mechanisms have limited their efficacy in treating

应助信息

2026-05-28

Book学术机器人

2026/5/28 14:07:16 未找到该文献，机器人已退出，请等待人工下载

2026/5/28 14:07:16 Book学术AI机器人收到请求，开始寻找文献

2026/5/28 14:07:16 已向机器人发送请求

2026-05-28

sifs 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAction of serine, cysteine, and aspartate proteases during optimized chickpea germination improved the generation of bioactive peptides